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Summary  
Background: Prenatal stress is associated with altered fetal and infant 
development. Previous studies have suggested that these effects may be 
mediated in part via altered functioning of placental enzymes and receptors 
involved in the HPA-axis, including the glucocorticoid receptor (NR3C1) and 
HSD11B2, the enzyme which metabolises cortisol. However, previous studies 
have not examined the potential ethnicity effects on these associations. This 
study aimed to characterise the association between maternal prenatal stress 
and placental genes expression and subsequently, any potential effect of 
maternal ethnicity.  
Method: Pregnant women(n=83) were recruited prior to elective caesarean 
section and assessed for trait anxiety, depression and life events. Placentas 
were collected and placental gene expression of NR3C1 and HSD11B2 were 
analysed. We examined associations between maternal prenatal stress and 
placental gene expression, and the tested for a possible moderating effect of 
maternal ethnicity(59.0% Caucasian;41.0% non-Caucasian:12.0% South 
Asian;6.0% African/African-American;14.4% Other;8.4% Mixed). 
Results: Analyses demonstrated a trend in the association between both 
maternal trait anxiety and depression symptoms with placental gene 
expression of NR3C1(adj.β=.220,p=.067;adj.β= .212,p=.064 respectively). We 
found a significant interaction with maternal ethnicity(=.249;p=.033). In 
Caucasian women only prenatal trait anxiety and depressive symptoms were 
associated with an increase in placental NR3C1 
expression(adj.=.389,p=.010;adj.=.294;p=.047 respectively). Prenatal life 
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events were associated with a down regulation of 
HSD11B2(adj.=.381;p=.008), but only in Caucasians.  
Conclusion:  These results support previous findings of an association 
between maternal prenatal stress and the expression of placental genes 
associated with the HPA-axis, but only in Caucasians. These ethnic specific 
findings are novel and require replication in different populations.  
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1. Introduction 
There is good evidence that maternal prenatal stress, including anxiety, depression 
and stressful life events, is associated with an increased risk of altered behavioural, 
cognitive and emotional development of the child (Glover et al., 2015; O'Connor et 
al., 2007; O'Connor et al., 2003). These changes in child development are, in turn, 
indicators of vulnerability for the development of psychopathology later in life 
(Schlotz and Phillips, 2009),  with an increase in psychiatric risk during later 
childhood and adolescence following exposure to maternal prenatal distress (Capron 
et al., 2015; O'Donnell et al., 2014; Pawlby et al., 2011; Pearson et al., 2013).  
However, the underlying biological changes that may mediate the associations 
between maternal prenatal mood and child outcome are not well understood. 
One potential mechanism is an alteration in the metabolism of cortisol by the 
placenta. Cortisol is known to cross the placenta, to some degree, and the 
correlation between maternal plasma and amniotic fluid cortisol has been found to 
be greater in more anxious mothers, suggesting an increased permeability to cortisol 
associated with raised anxiety (Glover et al., 2009). In animal studies, fetal exposure 
to raised levels of cortisol has been associated with a wide range of effects in 
offspring, including a reduction in birth weight, increase in adult blood pressure, and 
an increase in anxiety behaviours (Seckl and Holmes, 2007). In humans, fetal 
exposure to increased cortisol has been associated with a decrease in child cognitive 
function (Bergman et al., 2010).  
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The placenta has high levels of corticosteroid 11-beta-dehydrogenase 2 (HSD11B2), 
the enzyme that converts cortisol into inactive cortisone. This enzyme is located 
within the syncytiotrophoblast during the second and third trimester of human 
pregnancy (Pepe et al., 1999; Schoof et al., 2001). Studies in rodents have shown 
that exposure to maternal prenatal stress is associated with a decrease in the gene 
expression of placental HSD11B2 (Jensen Peña et al., 2012; Mairesse et al., 2007). 
Some human studies have also shown a down-regulation of HSD11B2 gene 
expression and reduction of enzymatic activity in the placentae of mothers with 
higher levels of prenatal anxiety (O'Donnell et al., 2012). This finding has been 
replicated in an Australian birth cohort, where high anxiety and depressive symptom 
scores at 28-34 weeks gestation were associated with a reduction in placental 
HSD11B2 gene expression (Seth et al., 2015). Monk et al. (2016) have found an 
association between maternal prenatal distress, placental methylation of HSD11B2 
and altered fetal behaviour (Monk et al., 2016). However, a study by Reynolds et al. 
reported no association between maternal depressive symptoms and placental gene 
expression of HSD11B2 (Reynolds et al., 2015). 
Maternal prenatal depression has been associated with an increase in the expression 
of the glucocorticoid receptor (NR3C1) gene in the placenta in several studies 
(Conradt et al., 2013; Mina et al., 2015; Reynolds et al., 2015). NR3C1 is a nuclear 
receptor which functions both a transcription factor and as a transcription factor 
regulator (Palma-Gudiel et al., 2015). NR3C1 has been shown to be expressed in 
placental tissue and although its function is unclear, it has been postulated that it 
may be an upstream regulator of placental HSD11B2 gene expression (Garbrecht and 
Schmidt, 2013). Thus an increase in placental NR3C1 gene expression may be a 
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mechanism through which the placenta increases its sensitivity to glucocorticoids 
and fetal glucocorticoid exposure (Seckl and Holmes, 2007). 
 
Thus previous research has shown that a range of different types of  prenatal  stress, 
including symptoms of anxiety, depression as well as life events, are associated with  
increased risk of altered outcome for the child  including psychopathology (Glover et 
al., 2014; Kinsella and Monk, 2009). Prenatal symptoms of both anxiety and 
depression have also been found to be associated with altered expression of HPA-
axis associated genes in the placenta.  The majority of this research has been 
conducted in predominantly Caucasian populations and therefore, it is currently 
unclear if there are different associations seen in different populations. It is 
important to study both Caucasian and non-Caucasian populations. The current 
study was designed to investigate the associations between maternal prenatal 
depressive symptoms, anxiety symptoms and life events with placental gene 
expression of NR3C1 and HSD2B11, and includes subjects with different ethnicities.  
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2. Methods  
2.1. Participants 
Study participants (n = 83) were recruited into the My Baby and Me (MBAM) Study 
the day before elective caesarean section at Queen Charlotte's and Chelsea Hospital, 
West London. Women with singleton pregnancies, with no known obstetric medical 
disorders and fluent in English were approached for this study. Within the MBAM 
Study, 140 women were approached, 95 women consented, 55 women declined. Of 
the 95 women who consented, 90 placentae samples were obtained (3 participants 
withdrew from the study, 2 participants were withdrawn as they were no longer 
eligible for the study). Women who took glucocorticoid medication during their 
pregnancy were excluded from the study. Ethical approval for the study was 
obtained from the National Research Ethics Service (London, Chelsea; REC Ref –
13/LO/1436). 
2.2. Maternal Questionnaires 
Mothers completed the following self-rating questionnaires shortly after 
recruitment. 
The Edinburgh Postnatal Depression Scale (EPDS), a widely used and well validated 
questionnaire was used to assess symptoms of maternal depression (Cox et al., 
1996; Cox et al., 1987). It has 10 questions with higher scores reflecting increased 
levels of depressive symptoms. 
The Spielberger Trait Anxiety Inventory (STAI) is comprised of 20-questions and is a 
widely used and well-validated questionnaire to assess symptoms of anxiety. The 
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STAI-Trait Anxiety sub-scale examines how a participant generally feels and higher 
scores indicate elevated maternal anxiety. 
The Life Events Questionnaire (LEQ) adapted from Barnett et al. (1983) is a 26-item 
maternal report of perceived stress relating to life event(s) during the course of 
pregnancy (Bergman et al., 2007). 
2.3. Obstetric and maternal demographic characteristics  
Information on maternal age, ethnicity, smoking (smoking vs. non-smoking), alcohol 
consumption (unit intake per week), prescription drug use, clinical indication for 
elective caesarean section, gestational age, and parity were collected at recruitment. 
Data on birth outcomes and infant sex were collected from hospital notes following 
delivery.  
2.4. Placental collection 
Healthy, intact placentas were collected immediately following delivery and 
dissected within 60 minutes. The umbilical cord was removed and the placental 
weight recorded. Tissue samples were taken from the maternal side of the placenta, 
at 5 random sampling sites. To ensure that the placental tissue was fetal in origin, 
the uppermost cotyledon surface was removed and trophoblast tissue taken from 
the central part of the placenta to include samples of the syncytiotrophoblastic 
region. The 5 samples were dissected in ice cold phosphate buffered saline (PBS), 
and pooled to control for intra-placental variation in gene expression. Samples were 
stored at −80 °C until required.  
2.5. RNA Preparation 
Total RNA was extracted from placental trophoblastic tissue using RNeasy Mini Kits 
(Qiagen, Crawley, UK), following the manufacturers protocol. RNA quantity was 
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assessed using a NanoDrop ND-1000 spectrophotometer (75–220 nm), whilst RNA 
integrity was examined using a Bioanalyzer 2100 (Agilent, Stockport, UK). Following 
previous recommendations, samples with an RNA integrity number ≥5 were 
considered of sufficient quality for subsequent use in cDNA synthesis and RT-PCR 
(Fleige and Pfaffl, 2006). 
2.6. Reverse transcriptase PCR 
cDNA was synthesised from RNA (2ηg/16μl) using the Superscript II system as per 
the manufacturer's instructions (Invitrogen, Paisley, UK). Genomic DNA was removed 
from RNA samples using a DNase treatment (DNase I, Invitrogen). Wells contained 
4.0μl of KiCqStart® SYBR® Green qPCR ReadyMix™ (Sigma-Aldrich, Dorset, UK), 2.6μl 
of DEPC-treated water and 0.4μl of appropriate forward and reverse primers, each at 
a concentration of 800nM. Non-template controls were run with 0.6μl of RNase free 
water to check for contamination, whilst 0.6μl of sample cDNA was added to all 
other wells, giving a total reaction volume of 8μl per well/reaction.  
Placenta HSD11B2 and NR3C1 gene expression analyses were assayed in duplicate 
and normalised to the geometric mean of ribosomal protein L19 and 14-3-3 protein 
YWHAZ using the following primer sequences: HSD11B2 forward: 
CTACTCATGGACACATTCAGCT, reverse: TCACTGACTCTGTCTTGAAGC; NR3C1 forward: 
CGACCAATGTAAACACATGCT, reverse: CCGTCCTTAGGAACTGAAGAG; L19 forward: 
ATTCTTCGTGTTACTACAGCTGAC, reverse: CATTCCTAAGGATGAAAGTAGCTC; YWHAZ 
forward: GATGACAAGAAAGGGATTGTCG, reverse: CAGTCTGATAGGATGTGTTGGT. 
There was a strong correlation between the two housekeeping genes (Rs= .597, p< 
.001).  
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RT-PCR was performed using a 7900 HT Fast Real-Time PCR System (Applied 
Biosystems, Warrington, UK). Cycling parameters were: (1) 2 min at 95 °C, (2) 5 sec 
at 94 °C and (3) 15 sec at 65 °C, with steps 2–3 being repeated for 40 cycles. The 
semi-quantitative assay provides information on the level of expression of the gene 
of interest and RT-PCR data is presented as as cycle threshold (ΔCt) values 
(Schmittgen and Livak, 2008). 
2.7. Data Analysis  
All statistical tests were performed using SPSS (v23.0). The placenta gene expression 
data was not normally distributed, so non-parametric statistical tests were used to 
analyse the data. Associations between maternal prenatal stress exposures (prenatal 
trait anxiety symptoms, depressive symptoms and life events) and the placental 
gene expression of HSD11B2 and NR3C1 were analysed using linear regression. 
Analyses were adjusted for covariates including maternal educational status, 
maternal prenatal smoking, and placental weight. These covariates were selected as 
they were significantly associated with either predictor or outcome variables. 
Maternal household income was not used as a covariate as it was not significantly 
associated with either the predictor or outcome variables. Previous research in this 
field has predominantly been conducted in Caucasian populations. Therefore, to test 
the effect of ethnicity within this sample, interaction analyses were conducted. For 
completeness, the effect of infant sex was also assessed using interaction analyses, 
but no significant interaction effects were observed. All variables included in the 
interaction terms were centred prior to analysis.  
11 
 
To ease interpretation gene expression values (expressed as cycle threshold (ΔCt) 
values) were inverted [x(−1)], such that a higher value represents an increase in gene 
expression. In addition, outliers, which fell outside the mean Ct value ± 3SD’s, were 
excluded from analyses (Number of outliers: HSD11B2 analyses=1; NR3C1 
analyses=3). Furthermore, placental weight for one participant was not obtained at 
the time of birth and this participant was therefore not included in the regression 
models.   
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3. Results 
The demographics and psychometric data for the participant group with placental 
gene expression data are shown in Table 1. The majority of participants had high 
levels of education, as is typical for the population from this hospital. With regard to 
maternal ethnicity, 59.0% were Caucasian; 12.0% South Asian; 6.0% African/African-
American; 14.4% other and 8.4% mixed ethnic groups. There was no significant 
difference between the Caucasian and non-Caucasian groups with regard to these 
demographic and psychometric variables. 
Table 1 here 
We found a trend in the association between placental NR3C1 gene expression and 
maternal prenatal trait anxiety symptoms (adj.= .211; p=  076). Maternal prenatal 
depressive symptoms was also weakly associated with placental NR3C1 gene 
expression (adj.= .212; p= .064).There was no evidence for an association between 
other measures of maternal prenatal stress and placental gene expression in the 
whole cohort (see Table 2). 
 
 
 
Table 2 here
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Previous research has been conducted in predominantly Caucasian populations and 
as this cohort was ethnically diverse, interaction analyses were undertaken to 
examine for a potential moderating effect of maternal ethnicity on the association 
between maternal prenatal stress and placental gene expression. There was a 
significant interaction between maternal prenatal trait anxiety symptoms and 
maternal ethnicity with respect to the placental gene expression of NR3C1 
(Interaction analysis; adj.β= .249, p= .033). Once the data was split by ethnicity, 
maternal trait anxiety symptoms was shown to be a significant positive predictor of 
NR3C1 gene expression in the Caucasian population (adj. = .389, p= .010) 
suggesting that higher anxiety symptoms in these mothers predicts an increase in 
placental NR3C1 gene expression (Figure 1A). However, there was no association 
seen between maternal prenatal trait anxiety symptoms and placental gene 
expression of NR3C1 in the non-Caucasian mothers (adj.= .091, p= .673). Although 
there was no significant interaction between maternal prenatal depressive 
symptoms and maternal ethnicity with placental NR3C1 gene expression (interaction 
analysis; = .133; p= .233), there was an association between maternal prenatal 
depressive symptoms and placental gene expression of NR3C1 in Caucasian women 
(adj.= .294, p= .047; Figure 1B). No such association was observed in non-
Caucasians (adj.= .176, p= .382).  
There was a significant interaction between maternal prenatal life events and 
maternal ethnicity with the placental gene expression of HSD11B2 (interaction 
analysis; adj.= -.385, p= .020).  Once split by ethnicity, there was a negative 
association between the number of prenatal life events in pregnancy and placental 
gene expression of HSD11B2 in the Caucasian population (adj.= -.381, p= .008; 
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Figure 1C). This association was not observed in the non-Caucasian population 
(adj.= .140, p= .445).  
To further explore which sub-group within the non-Caucasian group was driving 
these associations, correlations were conducted and suggest that these findings may 
be led by results from women who identified as being South Asian (Supplementary 
analyses 1) 
 
Figure 1 here. 
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4. Discussion 
This study showed a positive trend in the association between maternal prenatal 
anxiety and depressive symptoms with placental gene expression of NR3C1 in the 
whole cohort. No consistent evidence was found of an association between maternal 
prenatal anxiety and depressive symptoms and placental HSD11B2 gene expression. 
However, interaction analyses by ethnicity demonstrated marked differences 
between Caucasian and non-Caucasian mothers. In Caucasian participants, prenatal 
trait anxiety symptoms were predictive of an increase in placental NR3C1 gene 
expression, and prenatal life events were predictive of a decrease in HSD11B2 
placental gene expression. No such associations were observed in non-Caucasian 
women. Thus in the Caucasian women the study provides further evidence of an 
association between prenatal stress and expression of these placental genes 
associated with the HPA-axis, in the same direction as previous studies.  
There are several strengths to this study. Firstly, the study sample contained 
placental samples from an ethnically diverse population resulting in a novel focus. 
Previous research in this field has predominately involved Caucasian populations. 
Secondly, the placental samples were all collected and stored with one hour of 
delivery, which reduced the risk of tissue degradation. They were also obtained from 
subjects who had an elective caesarean, eliminating any possible effects of labour on 
gene expression (Cindrova-Davies et al., 2007). Finally, the gene expression within 
the placental tissue was calculated using the Ct method that corrects for internal 
variation between the placentae by adjusting for well-regulated and stable 
housekeeping genes (YWHAZ and L19) (Meller et al., 2005; Patel et al., 2002). 
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There were also a number of limitations to consider. The study population was modest 
in size with small numbers of women from a range of different non-Caucasian ethnic 
groups. The non-Caucasians were predominantly from the Indian subcontinent, but 
numbers from each sub-group were too small for further analysis, and as these are 
quite varied ethnic groups it is difficult to draw any firm conclusions about them. It 
remains possible that the differences observed between the Caucasians and the 
others are due to social rather than biological factors. They may have experienced past 
trauma or racism, for example, which may have altered their resilience. However, as 
Table 1 shows there were no significant differences in any of the demographic or 
psychometric parameters studied between the two groups. Further analyses of the 
sub-groups within the non-Caucasian population suggest that there these findings 
may be driven by those who identify as South Asian. However, due to the small size of 
the subgroup (n=10) it is difficult to extrapolate from these findings and further 
analyses within larger cohorts would be needed to examine these associations further.  
As the levels of prenatal stress were collected via self-report questionnaires, some 
caution is warranted, and they clearly do not represent clinical diagnoses. 
Additionally, there was only one-time point at which maternal prenatal anxiety and 
depression scores were assessed and this was at the end of pregnancy. As the 
participants completed their questionnaires prior to elective caesarean section this 
may have resulted in elevated scores, especially with regard to anxiety. We do not 
know how long such anxiety may have been raised, or how long changes in the gene 
expression take to occur. There was a lack of consistency in the findings with different 
maternal psychometric measures. As anxiety and depressive symptoms are highly co-
morbid one might have expected a larger degree of overlap within findings with 
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different but related predictors. We currently do not have enough evidence to 
determine whether symptoms of anxiety, depression or life event stress actually have 
a differential effect on the expression of the genes studied. 
 
When we consider our findings in the context of the existing scientific literature, we 
note that our findings  support previous research that has shown associations 
between maternal stress in pregnancy and upregulation of placental NR3C1 gene 
expression (Mina et al., 2015). Previous studies have also shown associations 
between antenatal depressive symptoms and increased DNA methylation of NR3C1 
and BDNF in infant buccal cells and in cord blood following exposure to antenatal 
depression (Braithwaite et al., 2015; Hompes et al., 2013; Oberlander et al., 2008). 
This increase in methylation suggests a reduction in gene expression of NR3C1 in the 
offspring and may be the result of overexposure to glucocorticoids in pregnancy 
through increased placental transmission of glucocorticoids.   
Maternal antenatal trait anxiety has previously been associated with a down 
regulation of placenta HSD11B2 gene expression (O'Donnell et al., 2012; Seth et al., 
2015). Indirect evidence in human studies  has shown that there is a correlation 
between cortisol concentrations in maternal  plasma and amniotic fluid (assessed at 
the point of amniocentesis) in highly anxious women when compared to non-anxious 
women (Glover et al., 2009). This suggests that there may be greater permeability of 
the fetal compartment to maternal cortisol levels in pregnancies exposed to higher 
levels of prenatal anxiety. However, the evidence to support the association 
between elevated maternal prenatal anxiety and depressive symptoms and placental 
HSD11B2 gene expression is mixed as a study by Reynolds et al. (2015) did not show 
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an association between maternal depression in pregnancy and placental gene 
expression of HSD11B2 (Reynolds et al., 2015). In the Caucasian population only, we 
have shown a down regulation of placental HSD11B2 associated with an increased 
number of life events experienced during pregnancy. This has not previously been 
demonstrated.  It will only be possible to resolve whether there are indeed 
differential effects between anxiety, depression and life events on placental gene 
expression with a much larger sample size.  
The majority of the current literature has been focused on populations, which are all, 
or predominantly, Caucasian in origin. The findings of the current study raise an 
interesting question, as to whether women from different ethnicities vary in their 
placental response to prenatal stress and furthermore whether any such difference 
might result in changes to infant  and child outcome associated with exposure to 
prenatal stress.  
There have been few studies that have examined the effect of maternal prenatal 
stress in non-Caucasian populations. The studies that there have been, span a wide 
range of ethnic populations and stressors and mostly focus on birth outcomes of the 
infant, such as birth weight and birth length. These studies suggest that maternal 
exposure to prenatal stressors such as common mental health disorders, war,  or 
physical violence can be associated with a reduction in birth weight (Ferri et al., 
2007; Mulligan et al., 2012; Nasreen et al., 2010; Niemi et al., 2013; Patel and Prince, 
2006; Rahman et al., 2007), reduction in birth length (Broekman et al., 2014), an 
increased risk of pre-term birth (Niemi et al., 2013), greater risk of fetal distress 
during delivery (Zahran et al., 2010), increased time in labour (Hanlon et al., 2009), 
delays in breastfeeding initiation (Hanlon et al., 2009) and admission to neonatal 
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intensive care (Chung et al., 2001). However, these studies did not examine the 
effects of these maternal stressors on offspring outcome with respect to maternal 
ethnicity. No studies to date have examined placental gene expression across 
different ethnic groups. One study in a non-Caucasian population demonstrated an 
association between maternal prenatal war exposure and the methylation status of 
NR3C1 in the cord blood of infants within a cohort from the Democratic Republic of 
Congo (Mulligan et al., 2012). These findings are similar to that of a study conducted 
in a Caucasian population, but this study was conducted on women experiencing 
prenatal depression rather than acute prenatal stress due to war exposure 
(Oberlander et al., 2008). Further studies are necessary to assess if there is any 
different effect of these maternal stressors on offspring outcome dependent on 
maternal ethnicity. 
In future studies it will of interest, as well as confirming the differences in placental 
expression in different ethnic groups, to determine whether this is associated with 
differences in child outcome. 
4.1. Conclusion 
This study provides further evidence that maternal prenatal stress is associated with 
changes in the placental gene expression of an enzyme and receptor involved in the 
HPA-axis. However, the associations were only observed in the Caucasian group and 
further research, using different cohorts, is needed to further explore this in 
different ethnic populations. 
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